Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70377-093

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70377-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cubicin 01)

Chemical structure of Daptomycin, depicting its molecular framework with various amino acid residues and functional groups characteristic of this antibiotic compound.*

FDA Label Image

Cartonlabel.jpg (Daptomycin 01)

Packaging label for Daptomycin for Injection 500 mg per vial, a lyophilized powder for intravenous infusion. The label states it must be refrigerated and is for single-dose use. It includes instructions to reconstitute with 0.9% Sodium Chloride Injection to obtain 50 mg/mL. The labeler is Biocon Pharma Inc., with manufacturing information noted. Packaging dimensions are 42mm by 70mm.*

FDA Label Image

Viallabel.jpg (Viallabel)

Daptomycin for injection 500 mg per vial, lyophilized powder for intravenous infusion. Label includes storage instructions to refrigerate at 2°C-8°C. Manufactured for Biocon Pharma Inc. and by Abryl Laboratories in India. Contains a barcode and a note to use 10 mL 0.9% sodium chloride injection for reconstitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.